Real Estate
The Motley Fool

3 Dividend Stocks to Double Up on Right Now

June 29, 2025
04:51 AM
4 min read
AI Enhanced
investmentstockshealthcareenergyreal estatemarket cyclesseasonal analysis

Key Takeaways

Buy, sell, or hold. That's the question investors must continually ask each stock in their portfolio. The correct answer might be to sell if your original thesis has changed. In...

Article Overview

Quick insights and key information

Reading Time

4 min read

Estimated completion

Category

real estate

Article classification

Published

June 29, 2025

04:51 AM

Source

The Motley Fool

Original publisher

Key Topics
investmentstockshealthcareenergyreal estatemarket cyclesseasonal analysis

That's the question investors must continually ask each stock in their portfolio

The correct answer might be to sell if your original thesis has changed

In many cases, the best course of action is to simply stay the course

Sometimes, though, adding more to your position makes sense

Every now and then, the smartest strategy is to back up the truck and load up on more s

Here are three dividend stocks to double up on right now

Image source: Getty Images

AbbVie If there were a dividend hall of fame, I think AbbVie (ABBV -1. 01%) should be in it

The major drugmaker is a Dividend King with 53 consecutive years of dividend increases

Since spinning off from Abbott in 2013, AbbVie has more than quadrupled its dividend payout

Its forward dividend yield currently tops 3

Why double up on AbbVie now

Its dividend is one reason

However, an even more compelling motivation is that the company's growth should accelerate nicely over the next few years

AbbVie continues to be somewhat weighed down by the early 2023 loss of exclusivity for its then-top-selling drug, Humira

But the more time passes, Humira will have less of a drag on growth

Meanwhile, sales for the company's two successors to Humira -- Rinvoq and Skyrizi -- are soaring

AbbVie's pipeline also features several potentially solid growth drivers

The main argument against more heavily in AbbVie stock now is bably the Trump administration's threats of tariffs on pharmaceutical imports to the U

And the implementation of a most-favored-nation drug pricing plan

I suspect, though, that these won't derail AbbVie's growth much, if at all, over the near term and will ly be non-issues in the long term

Enterprise ducts Partners Want especially juicy income

Take a look at Enterprise ducts Partners (EPD -0

This master limited partnership (MLP) offers a forward distribution yield of 6

Here's more good news: Enterprise has increased its distribution for 26 consecutive years

Yes, this sky-high distribution is a key factor behind my including Enterprise ducts Partners on the list of dividend stocks to double up on right now

The stock won't have to der much in the way of appreciation to generate a double-digit percentage total return

I expect this mid energy stock will vide nice growth, though

Is experiencing an explosion in the number of data centers, largely due to the breakneck adoption of artificial intelligence (AI)

Many of these data centers will be powered by natural gas

That's great news for Enterprise ducts Partners

Domestic demand isn't the only growth driver for Enterprise ducts Partners, either

As co-CEO Jim Teague said in the MLP's first-quarter earnings call, "The bottom line is the world needs U

Oil, natural gas, and natural gas liquids to vide for their people and to grow their economies. " He's right -- and much of those hydrocarbons will flow through Enterprise's pipelines

Realty Income Realty Income (O -0. 26%) is listed third among the dividend stocks to double up on now, but it's only because I've listed the stocks alphabetically

There's a lot to this real estate investment trust (REIT)

For starters, Realty Income's forward dividend yield is 5

The company distributes its dividend monthly

It has also increased its dividend for 30 consecutive years, with a total of 131 dividend hikes during that period

If that's not enough to impress you, consider that Realty Income has generated a positive total operational return every year since its initial public offering in 1994

The stock's average total return since then is roughly 11%

Realty Income's growth spects look good, too

The REIT targets a total addressable market of $14 trillion. 5 trillion of that market is in Europe, where the company has only two major rivals

Keith Speights has positions in AbbVie, Enterprise ducts Partners, and Realty Income

The Motley Fool has positions in and recommends AbbVie, Abbott Laboratories, and Realty Income

The Motley Fool recommends Enterprise ducts Partners

The Motley Fool has a disclosure policy.